This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Stanford Graduate School of Business (USA)
-
Note on Angel Financing
Strebulaev, I; Han, ACase SGSB-E440-EEntrepreneurshipAs administrative headcount grew dramatically from 6,800 to over 10,000, Singletary launched a major initiative to develop the University’s most promising managers through effective instruction and feedback. Among the attendees were Rita Torres, Dieter Kopp, and Marilyn Malkin. They were excited to be among the select group of Singletary Management Program participants, and were eager to receive expert teaching and peer guidance on how they could...Starting at €8.20
-
A Day in the Life of a Centure Capitalist
Strebulaev, I; Gouw-Ranzetta, T; Hoyt, DCase SGSB-E444-EEntrepreneurshipThis note describes the tasks that fill the working day of a venture capitalist. Those functions involved in investing (deal sourcing, due diligence, and related tasks) often receive the most attention from students. However, interviews with experienced venture capitalists found that as much or more time is spent working with existing portfolio companies. This note provides insight into each aspect of a venture capitalist’s job: making investm...Starting at €8.20
-
Evaluating Venture Capital Term Sheets
Strebulaev, I; Gouw-Ranzetta, T; Hoyt, DCase SGSB-E460-EEntrepreneurshipWhen entrepreneurs are successful in convincing venture capital firms that they are an attractive potential investment, they are presented with offers detailing many terms of the investment agreement. These are described in term sheets. Sorting through the myriad terms can be a daunting proposition for an entrepreneur. Yet, it is important for entrepreneurs to understand the terms of a proposed financing. These determine the payout the entrep...Starting at €8.20
-
Axel Springer in 2016: From Transformation to Acceleration
Burgelman, R; Siegel, R; Kissick, RCase SGSB-E610-EEntrepreneurshipAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Starting at €8.20
-
Axel Springer in 2014: Strategic Leadership of the Digital Media Transformation - Teaching Note
Burgelman, R; Siegel, R; Luther, JTeaching Note SGSB-E522TN-EEntrepreneurshipIn 2013, Mathias Döpfner, CEO of the publishing house Axel Springer SE, a premier source of content in Germany, with its popular newspapers and magazines such as Bild and Die Welt, was evaluating the progress of his company’s digital transformation. The advent of the digital revolution at the end of the twentieth century had caused an appreciable shift in the publishing industry. Traditional print media players were confronted with major techno...Starting at €0.00
-
DropBox - Series B Financing
Strebulaev, I; Foroughi, J; GouwCase SGSB-F309-EFinanceIn mid-2011, as global markets corrected amid worldwide economic uncertainty, Drew Houston, co-founder and CEO of Dropbox, the fast-growing file synchronization and sharing company, found himself in a difficult, albeit enviable, situation. Houston, who had already raised over $7 million through two rounds of venture funding (one seed round and a Series A round) and developed a large and growing user base, began receiving significant investor int...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20
-
The Chinese Wireless Communications Industry in 2012 and Beyond: An Industry Note - Teaching Note
Burgelman, R; Gang, Zheng,, Yajuan, WangTeaching Note SGSB-SM227TN-EStrategyThis industry note provides an extensive overview of the wireless communications industry in China at the end of 2012. At the time China had over 1.1 billion mobile subscribers, and the country was predicted to have 500 million smartphones in use by the end of 2013. The note discusses the industry’s value chain (carriers, device manufactures, component providers, content and applications providers, and telecom equipment providers), and the role o...Starting at €0.00